ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

In Brief: Broder Resigns From IVX; Bishop To Receive Public Service Award; Johnston Rejoins NIAID

August 7, 1998

Judge Clears Way For Trial Pitting FDA Against Physicians Over First Amendment

March 24, 1995

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979

James Watkins To Head AIDS Commission Following Mayberry’s Resignation

October 16, 1987

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002